Key facts
- Sonosine’s last known valuation is $1.8M (Jan 2025).
- It has raised $4.8M; the latest was Seed Round in Jul 2025.
- Notable investors include University of Oxford, Oxford Science Enterprises, Frederic Hoffman, Heping Zhang, Jonathan Gillbanks — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Sonosine
- ·The full record, as it builds
Funding rounds
No funding rounds for Sonosine are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sonosine
Developer of a core medical imaging technology designed to transform clinicians' use of ultrasound diagnostics. The company's technology improves clinical decision-making by using a patented EMA imaging technology that makes quality medical diagnostics quick, safe, and comfortable for patients, enabling clinicians to get reliable images that allow informed and efficient decision-making.
- Sector
- Healthcare
- HQ
- Begbroke, United Kingdom
- Founded
- 2015
- Employees
- 8
- Website
- sonosine.com/
- Ownership
- Privately Held (backing)
Sonosine doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sonosine shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sonosine in its N-PORT filings yet. We sweep new filings monthly.